Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 2/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.31 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.31 |
| ▸ | POLB | P06746 | 1/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL46100 | 0.92 | EPHX2 (0.34) | MEN1KMT2AMAPK1EPHX2POLB | |
| SCHEMBL12071750 | 0.92 | KDM4E (0.32) | MEN1KMT2AALDH1A1 | |
| SCHEMBL46375 | 0.92 | NPSR1 (0.31) | MEN1KMT2AEPHX2POLBALDH1A1 | |
| SCHEMBL12071745 | 0.91 | EZH2 (0.32) | MEN1KMT2APOLBALDH1A1 | |
| SCHEMBL46054 | 0.88 | L3MBTL1 (0.30) | — | |
| SCHEMBL12574778 | 0.88 | MEN1 (0.30) | MEN1KMT2AMAPK1 | |
| SCHEMBL46053 | 0.88 | SIGMAR1 (0.32) | MEN1KMT2AALDH1A1 | |
| SCHEMBL19139584 | 0.88 | KMT2A (0.34) | MEN1KMT2AMAPK1EPHX2ALDH1A1 | |
| SCHEMBL46056 | 0.86 | MEN1 (0.37) | MEN1KMT2AMAPK1EPHX2POLB | |
| SCHEMBL12573637 | 0.85 | HRH3 (0.31) | ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2011151249-A2 | METHOD OF CONTROLLING NEONICOTINOID RESISTANT HEMIPTERA | SYNGENTA PARTICIPATIONS AG (CH) | 2011-12-08 | — | — | WO | disclosed |
| WO-2010066780-A1 | SPIROHETEROCYCLIC N-OXYPIPERIDINES AS PESTICIDES | SYNGENTA PARTICIPATIONS AG (CH) | 2010-06-17 | — | — | WO | disclosed |